0001179110-18-010754.txt : 20180822
0001179110-18-010754.hdr.sgml : 20180822
20180822102959
ACCESSION NUMBER: 0001179110-18-010754
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180820
FILED AS OF DATE: 20180822
DATE AS OF CHANGE: 20180822
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taylor Beth
CENTRAL INDEX KEY: 0001522046
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35050
FILM NUMBER: 181031696
MAIL ADDRESS:
STREET 1: 3000 KENT AVENUE
STREET 2: SUITE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENDOCYTE INC
CENTRAL INDEX KEY: 0001235007
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 KENT AVE STE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
BUSINESS PHONE: 7654637175
MAIL ADDRESS:
STREET 1: 3000 KENT AVE STE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
4
1
edgar.xml
FORM 4 -
X0306
4
2018-08-20
0
0001235007
ENDOCYTE INC
ECYT
0001522046
Taylor Beth
3000 KENT AVE, STE A1-100
WEST LAFAYETTE
IN
47906
0
1
0
0
VP Finance & Chief Acctg Offcr
Common Stock
2018-08-20
4
S
0
285
18.2001
D
71255
D
Represents the sale of 285 shares in a single transaction, at a price per share of $18.2001. The 285 shares were sold to cover taxes, commissions and fees associated with the August 18, 2018 settlement of 938 restricted stock units in the form of Company common stock on a one-for-one basis. The shares were sold by Merrill Lynch pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934 adopted by the reporting person on July 30, 2018.
/s/ Beth A. Taylor
2018-08-22